Jump to Content
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
Sign in
Sign up
SEARCH
Advanced Search
Help
Sign in
Sign up
HOME
BROWSE
SUBJECTS
CLINICAL RESOURCES
DRUG INFORMATION
EDUCATION AND TRAINING
PHARMACY PRACTICE
CAREER DEVELOPMENT
AJHP
DRUG INFORMATION
PROFESSIONAL DEVELOPMENT
SEARCH
Advanced Search
Help
Search
Table of Contents
Front Matter
Preliminary Material
ASHP Policy Positions, Statements, Guidelines, and Technical Assistance Bulletins
Automation and Information Technology
Show Items
Drug Distribution and Control
Show Items
Education and Training
Show Items
Ethics
Show Items
Formulary Management
Formulary Management
ASHP Statement on the Use of Medications for Unlabeled Uses
ASHP Guidelines on Medication-Use Evaluation
ASHP Guidelines on the Pharmacy and Therapeutics Committee and the Formulary System
Principles of a Sound Drug Formulary System
Government, Law, and Regulation
Show Items
Medication Safety
Show Items
Medication Therapy and Patient Care
Show Items
Pharmaceutical Industry
Show Items
Pharmacy Management
Show Items
Practice Settings
Show Items
Research
Show Items
ASHP Therapeutic Position Statements
Show Items
ASHP Therapeutic Guidelines
Show Items
ASHP Statement on the Use of Medications for Unlabeled Uses
in
Best Practices
Author:
Bruce Hawkins
DOI:
https://doi.org/10.37573/9781585287048.039
Restricted access
Email this content
Share Link
Copy this link, or click below to email it to a friend
Email this content
or copy the link directly:
https://publications.ashp.org/abstract/book/9781585287048/chapter039.xml
The link was not copied. Your current browser may not support copying via this button.
Link copied successfully
Copy link
Share on facebook
Share on linkedin
Share on twitter
[18.97.9.174]
18.97.9.174
Sign in to annotate
Close
Edit
Character limit
500
/500
Delete
Cancel
Save
@!
Character limit
500
/500
Cancel
Save
View Expanded
View Table
View Full Size
